Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
Abstract The human 2-oxoglutarate dependent oxygenase aspartate/asparagine-β-hydroxylase (AspH) catalyses the hydroxylation of Asp/Asn-residues in epidermal growth factor-like domains (EGFDs). AspH is upregulated on the surface of malign cancer cells; increased AspH levels correlate with tumour inva...
Guardado en:
Autores principales: | Lennart Brewitz, Anthony Tumber, Inga Pfeffer, Michael A. McDonough, Christopher J. Schofield |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/86f4a7c44ed5487c8df924d7752ecc2e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Aspartate/asparagine-β-hydroxylase: a high-throughput mass spectrometric assay for discovery of small molecule inhibitors
por: Lennart Brewitz, et al.
Publicado: (2020) -
Aspartate/asparagine-β-hydroxylase crystal structures reveal an unexpected epidermal growth factor-like domain substrate disulfide pattern
por: Inga Pfeffer, et al.
Publicado: (2019) -
p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival
por: Longfei Deng, et al.
Publicado: (2020) -
2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases
por: Yu Nakashima, et al.
Publicado: (2021) -
Precision multidimensional assay for high-throughput microRNA drug discovery
por: Benjamin Haefliger, et al.
Publicado: (2016)